
    
      Two 21-day cycles of pemetrexed (500 milligrams per square meter [mg/m2] intravenous [IV]
      infusion) and carboplatin (target area under the curve [AUC] 5 IV infusion) followed by two
      21-day cycles of pemetrexed (500 mg/m2 IV infusion) and carboplatin (target AUC 5 IV
      infusion) with concurrent radiotherapy (2 Gray [Gy] per fraction, 5 fractions per week, up to
      a dose of 50 Gy is administered).
    
  